ArticleCancer letters2022
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.
Prabhakar Pitta Venkata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it